Can Adropin and Preptin be a Prognostic Marker and aPotential Therapeutic Target in Prostate Cancer?

Sürdürülebilir Kalkınma Amaçları

• SKA 3: Sağlıklı Bireyler

Atıf için künye

ERASLAN, E., TOPDAĞI, Ö., Tanyeli, A., Güler, M. C., ŞEBİN, E., Özbek Şebin, S., & POLAT, E. (2018). Can Adropin and Preptin be a Prognostic Marker and aPotential Therapeutic Target in Prostate Cancer? Turkish Society of Physiological Sciences 44th National Physiology Congress.

@inproceedings{eraslan2018-210283,
  author = {ERASLAN, ERSEN and TOPDAĞI, ÖMER and Tanyeli, Ayhan and Güler, Mustafa Can and ŞEBİN, ENGİN and Özbek Şebin, Saime and POLAT, ELİF},
  title = {Can Adropin and Preptin be a Prognostic Marker and aPotential Therapeutic Target in Prostate Cancer?},
  booktitle = {Turkish Society of Physiological Sciences 44th National Physiology Congress},
  year = {2018},
  url = {https://akademik.atauni.edu.tr/yayinlar/210283-can-adropin-and-preptin-be-a-prognostic-marker-and-apotential-therapeutic-target}
}